Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06158568Not ApplicableCompleted

Percutaneous Electrical Nerve Stimulation and Exercise for Shoulder Pain

Role: lead

NCT02188394Phase 2Completed

Anesthetic Blockades and Migraine

Role: lead

NCT02172079Not ApplicableCompleted

Mobilization With Movement for Shoulder Impingement

Role: lead

NCT02122315Not ApplicableCompleted

Dry Needling in Post-operative Shoulder Pain

Role: lead

NCT01790074Not ApplicableCompleted

Trigger Point Therapy in Cervicogenic Headache

Role: lead

All 5 trials loaded